3.82
price down icon4.50%   -0.18
after-market 시간 외 거래: 3.98 0.16 +4.19%
loading
전일 마감가:
$4.00
열려 있는:
$3.95
하루 거래량:
177.37K
Relative Volume:
0.44
시가총액:
$27.70M
수익:
-
순이익/손실:
$-29.01M
주가수익비율:
-0.079
EPS:
-48.3535
순현금흐름:
$-29.34M
1주 성능:
-2.55%
1개월 성능:
-21.88%
6개월 성능:
-49.74%
1년 성능:
+0.53%
1일 변동 폭
Value
$3.74
$3.95
1주일 범위
Value
$3.60
$4.03
52주 변동 폭
Value
$0.61
$14.68

Briacell Therapeutics Corp Stock (BCTX) Company Profile

Name
명칭
Briacell Therapeutics Corp
Name
전화
(604) 921-1810
Name
주소
3RD FLOOR, BELLEVUE CENTRE, 235-15TH STR, WEST VANCOUVER
Name
직원
4
Name
트위터
Name
다음 수익 날짜
2024-10-28
Name
최신 SEC 제출 서류
Name
BCTX's Discussions on Twitter

Compare BCTX vs VRTX, REGN, ARGX, ALNY, ONC

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
BCTX
Briacell Therapeutics Corp
3.82 29.00M 0 -29.01M -29.34M -48.35
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
496.83 121.97B 12.07B 3.95B 3.19B 15.33
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
781.67 81.49B 14.34B 4.50B 3.77B 41.56
Biotechnology icon
ARGX
Argen X Se Adr
766.92 47.74B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
332.92 43.93B 3.71B 313.75M 465.38M 2.2571
Biotechnology icon
ONC
Beone Medicines Ltd Adr
316.99 35.67B 4.98B 69.60M 525.67M 0.5198

Briacell Therapeutics Corp Stock (BCTX) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2022-02-14 개시 H.C. Wainwright Buy

Briacell Therapeutics Corp 주식(BCTX)의 최신 뉴스

pulisher
Feb 23, 2026

Street Watch: Is BriaCell Therapeutics Corp a defensive stock2025 Performance Recap & Capital Efficiency Focused Ideas - baoquankhu1.vn

Feb 23, 2026
pulisher
Feb 23, 2026

BriaCell and BriaPro Enter Into Asset Purchase Agreement for Exclusive Soluble CD80 License - National Today

Feb 23, 2026
pulisher
Feb 20, 2026

BriaCell Restructures Soluble CD80 Program via BriaPro Deal - TipRanks

Feb 20, 2026
pulisher
Feb 20, 2026

BriaCell enters asset sale to BriaPro for sCD80, receives 23.97M shares and up to $3M credit - TradingView

Feb 20, 2026
pulisher
Feb 20, 2026

(BCT) Investment Performance Report (BCT:CA) - Stock Traders Daily

Feb 20, 2026
pulisher
Feb 20, 2026

Is BriaCell Therapeutics Corp. stock a top pick in earnings seasonJuly 2025 Catalysts & Risk Adjusted Buy and Sell Alerts - mfd.ru

Feb 20, 2026
pulisher
Feb 19, 2026

Bull Run: What is BriaCell Therapeutics Corp. Equity Warrant’s valuation compared to sector2025 Geopolitical Influence & Weekly Setup with High ROI Potential - mfd.ru

Feb 19, 2026
pulisher
Feb 19, 2026

BriaCell Adds UCLA Health as Key Site in Pivotal Phase 3 Breast Cancer Study - Intellectia AI

Feb 19, 2026
pulisher
Feb 18, 2026

BriaCell (BCTX) Expands Biologic Cancer Treatments Through New A - GuruFocus

Feb 18, 2026
pulisher
Feb 18, 2026

BriaPro to Acquire BriaCell’s Soluble CD80 License in Strategic Cancer Immunotherapy Deal - TipRanks

Feb 18, 2026
pulisher
Feb 18, 2026

BriaCell Therapeutics Brief: BriaCell and BriaPro Entering Into Asset Purchase Agreement for Exclusive Soluble CD80 License - marketscreener.com

Feb 18, 2026
pulisher
Feb 17, 2026

Will BriaCell Therapeutics Corp. Equity Warrant stock maintain momentum in 2025Market Activity Report & Verified Chart Pattern Signals - mfd.ru

Feb 17, 2026
pulisher
Feb 17, 2026

BriaCell Therapeutics Corp. Receives Positive Recommendation from Data Safety Monitoring Board for Phase 3 Study in Metastatic Breast Cancer - marketscreener.com

Feb 17, 2026
pulisher
Feb 17, 2026

(BCT) Technical Patterns and Signals (BCT:CA) - Stock Traders Daily

Feb 17, 2026
pulisher
Feb 17, 2026

BriaCell Wins Fifth Straight Safety Nod for Fast-Track Phase 3 Breast Cancer Trial - TipRanks

Feb 17, 2026
pulisher
Feb 17, 2026

BriaCell Therapeutics' Phase 3 Breast Cancer Treatment Trial Gets Fifth DSMB Recommendation to Continue - marketscreener.com

Feb 17, 2026
pulisher
Feb 17, 2026

Data Safety Review Board Issues Positive Safety Recommendation For BriaCell's Phase 3 Study - marketscreener.com

Feb 17, 2026
pulisher
Feb 17, 2026

BriaCell Receives Positive Recommendation from Data Safety Monitoring Board (DSMB) for Phase 3 Study in Metastatic Breast Cancer - The Manila Times

Feb 17, 2026
pulisher
Feb 17, 2026

BriaCell Receives Positive Recommendation from Data Safety - GlobeNewswire

Feb 17, 2026
pulisher
Feb 16, 2026

BriaCell Awarded New Zealand Patent for its Whole Cell Technology - Intellectia AI

Feb 16, 2026
pulisher
Feb 15, 2026

Why BriaCell Therapeutics Corp. stock could be next big winnerTrade Exit Summary & High Conviction Buy Zone Alerts - mfd.ru

Feb 15, 2026
pulisher
Feb 15, 2026

What is BriaCell Therapeutics Corp. Equity Warrant s debt to equity ratioJuly 2025 Spike Watch & Consistent Return Investment Signals - mfd.ru

Feb 15, 2026
pulisher
Feb 14, 2026

Entry Recap: Will BriaCell Therapeutics Corp. stock go up in YEARTrade Risk Report & Long-Term Safe Investment Ideas - mfd.ru

Feb 14, 2026
pulisher
Feb 14, 2026

Is now the right time to enter BriaCell Therapeutics Corp.2025 Fundamental Recap & Risk Controlled Daily Plans - mfd.ru

Feb 14, 2026
pulisher
Feb 14, 2026

Will BriaCell Therapeutics Corp. Equity Warrant announce a stock splitJuly 2025 Rallies & Daily Volume Surge Signals - mfd.ru

Feb 14, 2026
pulisher
Feb 14, 2026

Can BriaCell Therapeutics Corp. stock maintain growth trajectoryPrice Action & Free Low Drawdown Momentum Trade Ideas - mfd.ru

Feb 14, 2026
pulisher
Feb 14, 2026

(BCT) Equity Trading Insights (BCT:CA) - Stock Traders Daily

Feb 14, 2026
pulisher
Feb 14, 2026

Published on: 2026-02-14 21:45:18 - mfd.ru

Feb 14, 2026
pulisher
Feb 14, 2026

Does BriaCell Therapeutics Corp. Equity Warrant have pricing powerMarket Activity Report & Technical Confirmation Alerts - mfd.ru

Feb 14, 2026
pulisher
Feb 12, 2026

Will BriaCell Therapeutics Corp. Equity Warrant stock outperform value stocks2025 Winners & Losers & Community Verified Swing Trade Signals - mfd.ru

Feb 12, 2026
pulisher
Feb 12, 2026

Does BriaCell Therapeutics Corp. stock have upside surprise potentialJuly 2025 Momentum & Consistent Return Strategy Ideas - mfd.ru

Feb 12, 2026
pulisher
Feb 11, 2026

Is now the right time to enter BriaCell Therapeutics Corp. Equity Warrant2025 Volume Leaders & Safe Capital Growth Tips - mfd.ru

Feb 11, 2026
pulisher
Feb 11, 2026

When (BCT) Moves Investors should Listen (BCT:CA) - Stock Traders Daily

Feb 11, 2026
pulisher
Feb 08, 2026

(BCT) Long Term Investment Analysis (BCT:CA) - Stock Traders Daily

Feb 08, 2026
pulisher
Feb 07, 2026

Published on: 2026-02-07 21:02:33 - baoquankhu1.vn

Feb 07, 2026
pulisher
Feb 07, 2026

Published on: 2026-02-07 19:20:19 - baoquankhu1.vn

Feb 07, 2026
pulisher
Feb 06, 2026

Market Recap: Does BriaCell Therapeutics Corp align with a passive investing strategyWeekly Stock Recap & Safe Entry Zone Identification - baoquankhu1.vn

Feb 06, 2026
pulisher
Feb 06, 2026

Published on: 2026-02-06 19:26:35 - baoquankhu1.vn

Feb 06, 2026
pulisher
Feb 04, 2026

Published on: 2026-02-04 18:01:12 - baoquankhu1.vn

Feb 04, 2026
pulisher
Feb 03, 2026

Stocks in play: BriaCell Therapeutics Corp. - Barchart.com

Feb 03, 2026
pulisher
Feb 01, 2026

Big Picture: Should I buy BriaCell Therapeutics Corp Equity Warrant stock nowEarnings Recap Report & AI Enhanced Market Trend Forecasts - baoquankhu1.vn

Feb 01, 2026
pulisher
Jan 31, 2026

How does BriaCell Therapeutics Corp. Equity Warrant compare to its peersJuly 2025 Momentum & Weekly Watchlist for Consistent Profits - mfd.ru

Jan 31, 2026
pulisher
Jan 29, 2026

Will BriaCell Therapeutics Corp. stock hit new highs in YEAR2025 Risk Factors & AI Powered Trade Plan Recommendations - mfd.ru

Jan 29, 2026
pulisher
Jan 29, 2026

What’s the profit margin of BriaCell Therapeutics Corp. Equity WarrantPortfolio Gains Summary & Weekly Top Stock Performers List - mfd.ru

Jan 29, 2026
pulisher
Jan 28, 2026

BriaCell Brief: Says Patients' Images Show Regression And Resolution Of Metastasized Tumors And Immune Activation - marketscreener.com

Jan 28, 2026
pulisher
Jan 28, 2026

(BCT) Equity Market Report (BCT:CA) - Stock Traders Daily

Jan 28, 2026
pulisher
Jan 28, 2026

BriaCell Therapeutics (BCTX) Shows Promising Results in Metastatic Breast Cancer Treatment - GuruFocus

Jan 28, 2026
pulisher
Jan 28, 2026

BriaCell Treatment Shows Significant Efficacy in Cancer Patients - Intellectia AI

Jan 28, 2026
pulisher
Jan 28, 2026

BriaCell Patients’ Images Show Regression and Resolution of Metastasized Tumors and Immune Activation - Sahm

Jan 28, 2026
pulisher
Jan 27, 2026

Can BriaCell Therapeutics Corp. ride the EV waveJuly 2025 Pullbacks & Accurate Buy Signal Alerts - mfd.ru

Jan 27, 2026
pulisher
Jan 27, 2026

BriaCell reports long-term survival data in metastatic breast cancer By Investing.com - Investing.com India

Jan 27, 2026

Briacell Therapeutics Corp (BCTX) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$101.27
price up icon 1.18%
$28.94
price up icon 1.58%
$53.57
price up icon 3.60%
$110.23
price up icon 1.31%
$149.33
price down icon 0.45%
biotechnology ONC
$316.99
price down icon 1.67%
자본화:     |  볼륨(24시간):